Tanya B. Dorff, Leonard Joseph Appleman, Chia-Chi Lin, Jae Lyun Lee, Ben Tran, Stefanie Fischer, Daniel Danila, Priya Gokani, Brad Gallent, David William Pook. "XALience: A phase 3, open-label, multicenter, randomized study of xaluritamig plus abiraterone vs investigator’s choice in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5144